资讯

Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...
Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...
Endo International is the latest drugmaker ... opioid settlement and corporate restructuring terms – as well as Mallinckrodt, which emerged from chapter 11 after agreeing a $1.6 billion ...
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food ...
Endo Pharmaceuticals has announced it will remove its Opana ER opioid painkiller from the US market, a month after the FDA requested because of the potential for abuse. Dublin-based Endo said that ...
MALVERN, Pa., April 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of a Spatial Computing Injection Simulator for Peyronie's disease. The simulator allows urology ...
However, larger companies may find it easier and less expensive to fund an acquisition or merger at the current ... including AstraZeneca, Mallinckrodt, and Hansoh Pharmaceutical.
In an era where football increasingly revolves around data, minutes played, and resale value, some voices still cut through with clarity — and Virgil van Dijk’s backing of Wataru Endo is a ...
Wataru Endo has become something of a forgotten figure at Liverpool this season under Arne Slot. The Japanese international has been forced into a bit-part role with the Dutch manager with the 32-year ...